Race Oncology is pleased to announce the company has been invited to present at the ‘Biotech Showcase’ during the J.P. Morgan Healthcare Conference in San Francisco next week. Race Oncology Chief
Swiss biotech company TargImmune is announcing a new international research collaboration with Australia’s oldest medical research institute, the Walter and Eliza Hall Institute, to progress the
In November 2017, Race CEO Peter Molloy spoke to investors in London at the Biotech & Money conference.
What is Bisantrene and where did it come from? Click here to watch CEO Peter Molloy’s interview on Edison TV.
A Perth family tells the story of their son’s battle with Acute Myeloid Leukaemia. When Kai got sick, they searched the world for answers.
Race Oncology Limited (RAC) is pleased to announce it has produced its first good manufacturing practice (GMP) batch of cancer drug Bisantrene. The first batch will be enough to treat up to sixty
Betadine is the largest selling sore throat treatment in Australia. But it almost never made it to the shelves of our pharmacies and supermarkets. The active ingredient was developed by an